Fellows
Michael D. Iglesia

Michael D. Iglesia, MD, PhD

Third-year Fellow

Began fellowship in 2019

Biosketch

Education
2005-2008 BS, Guilford College, Greensboro, NC
2009-2017 MD/PhD, University of North Carolina, Chapel Hill, NC
Post-graduate Training
2017-2019 Residency, Internal Medicine, Barnes-Jewish Hospital, St. Louis, MO

Publications

  • Cancer Immunotherapy
    Iglesia MD, Johanns TM
    In: The Washington Manual of Oncology, 4th Edition (Morgensztern D, Ghobadi A, Govindan R, Editors), Wolters Kluwer, Philadelphia, 2022
  • Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
    Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ
    Cell Rep 2018 Aug 7;24(6):1434-1444e7
  • Treg Depletion Potentiates Checkpoint Inhibition in Claudin-Low Breast Cancer
    Taylor NA, Vick SC, Iglesia MD, Brickey WJ, Midkiff BR, McKinnon KP, Reisdorf S, Anders CK, Carey LA, Parker JS, Perou CM, Vincent BG, Serody JS
    J Clin Invest 2017 Sep 1;127(9):3472-3483
  • Assembly-Based Inference of B-Cell Receptor Repertoires From Short Read RNA Sequencing Data With V'DJer
    Mose LE, Selitsky SR, Bixby LM, Marron DL, Iglesia MD, Serody JS, Perou CM, Vincent BG, Parker JS
    Bioinformatics 2016 Dec 15;32(24):3729-3734
  • Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
    Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG
    J Natl Cancer Inst 2016 Jun 22;108(11)
  • Claudin-Low Bladder Tumors Are Immune Infiltrated and Actively Immune Suppressed
    Kardos J, Chai S, Mose LE, Selitsky SR, Krishnan B, Saito R, Iglesia MD, Milowsky MI, Parker JS, Kim WY, Vincent BG
    JCI Insight 2016 Mar 17;1(3):e85902
  • Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
    Carey LA, Berry DA, Cirrincione CT, Barry WT, Pitcher BN, Harris LN, Ollila DW, Krop IE, Henry NL, Weckstein DJ, Anders CK, Singh B, Hoadley KA, Iglesia M, Cheang MC, Perou CM, Winer EP, Hudis CA
    J Clin Oncol 2016 Feb 20;34(6):542-9
  • Prognostic B-Cell Signatures Using mRNA-Seq in Patients With Subtype-Specific Breast and Ovarian Cancer
    Iglesia MD, Vincent BG, Parker JS, Hoadley KA, Carey LA, Perou CM, Serody JS
    Clin Cancer Res 2014 Jul 15;20(14):3818-29
  • Comprehensive Molecular Portraits of Human Breast Tumours
    Cancer Genome Atlas Network (Contributors include: Iglesia MD)
    Nature 2012 Oct 4;490(7418):61-70
  • Tumor-Specific Retargeting of an Oncogenic Transcription Factor Chimera Results in Dysregulation of Chromatin and Transcription
    Patel M, Simon JM, Iglesia MD, Wu SB, McFadden AW, Lieb JD, Davis IJ
    Genome Res 2012 Feb;22(2):259-70